Borroto-Esoda K - Search Results

1

Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients.

Waters JM, O'Neal W, White KL, Wakeford C, Lansdon EB, Harris J, Svarovskaia ES, Miller MD, Borroto-Esoda K. Waters JM, et al. Antivir Ther. 2009;14(2):231-9. Antivir Ther. 2009. PMID: 19430098

2

In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.

Borroto-Esoda K, Vela JE, Myrick F, Ray AS, Miller MD. Borroto-Esoda K, et al. Antivir Ther. 2006;11(3):377-84. Antivir Ther. 2006. PMID: 16759055

3

Low-level K65R mutation in HIV-1 reverse transcriptase of treatment-experienced patients exposed to abacavir or didanosine.

Svarovskaia ES, Margot NA, Bae AS, Waters JM, Goodman D, Zhong L, Borroto-Esoda K, Miller MD. Svarovskaia ES, et al. J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):174-80. doi: 10.1097/QAI.0b013e31814258c0. J Acquir Immune Defic Syndr. 2007. PMID: 17667333 Clinical Trial.

4

A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.

Borroto-Esoda K, Parkin N, Miller MD. Borroto-Esoda K, et al. Antivir Chem Chemother. 2007;18(5):297-300. doi: 10.1177/095632020701800505. Antivir Chem Chemother. 2007. PMID: 18046962 Free article.

5

The A62V and S68G mutations in HIV-1 reverse transcriptase partially restore the replication defect associated with the K65R mutation.

Svarovskaia ES, Feng JY, Margot NA, Myrick F, Goodman D, Ly JK, White KL, Kutty N, Wang R, Borroto-Esoda K, Miller MD. Svarovskaia ES, et al. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):428-36. doi: 10.1097/QAI.0b013e31817bbe93. J Acquir Immune Defic Syndr. 2008. PMID: 18614922

6

Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen.

Svarovskaia ES, Curtis M, Zhu Y, Borroto-Esoda K, Miller MD, Berg T, Lavocat F, Zoulim F, Kitrinos KM. Svarovskaia ES, et al. J Viral Hepat. 2013 Feb;20(2):131-40. doi: 10.1111/j.1365-2893.2012.01638.x. Epub 2012 Jul 9. J Viral Hepat. 2013. PMID: 23301548

7

MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples.

Svarovskaia ES, Moser MJ, Bae AS, Prudent JR, Miller MD, Borroto-Esoda K. Svarovskaia ES, et al. J Clin Microbiol. 2006 Nov;44(11):4237-41. doi: 10.1128/JCM.01512-06. Epub 2006 Sep 27. J Clin Microbiol. 2006. PMID: 17005757 Free PMC article.

8

Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials.

Borroto-Esoda K, Miller MD, Arterburn S. Borroto-Esoda K, et al. J Hepatol. 2007 Oct;47(4):492-8. doi: 10.1016/j.jhep.2007.06.011. Epub 2007 Jul 23. J Hepatol. 2007. PMID: 17692425

9

Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz.

Borroto-Esoda K, Waters JM, Bae AS, Harris JL, Hinkle JE, Quinn JB, Rousseau FS. Borroto-Esoda K, et al. AIDS Res Hum Retroviruses. 2007 Aug;23(8):988-95. doi: 10.1089/aid.2006.0310. AIDS Res Hum Retroviruses. 2007. PMID: 17725415 Clinical Trial.

10

Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.

Zhu Y, Curtis M, Qi X, Miller MD, Borroto-Esoda K. Zhu Y, et al. Antivir Chem Chemother. 2009;19(4):165-76. doi: 10.1177/095632020901900404. Antivir Chem Chemother. 2009. PMID: 19374144 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters